Valuation: Uscom Limited

Market Cap 3.12M 2.07M 1.89M 1.74M 1.58M 2.97M 192M 21.18M 8.42M 105M 7.78M 7.62M 329M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 2.94M 2.67M 2.46M 2.24M 4.2M 272M 29.99M 11.92M 148M 11.01M 10.78M 466M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
3 years 0.01
Extreme 0.011
0.04
5 years 0.01
Extreme 0.011
0.13
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 06/03/2011
Corporate Secretary 66 23/05/2016
Corporate Officer/Principal - 27/05/2018
Director TitleAgeSince
Chairman - 31/10/2009
Director/Board Member 66 22/08/2018
Director/Board Member 62 15/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%-.--%-75.51% 2.07M
-2.79%-4.38%+13.97%+38.80% 248B
-3.16%-5.43%-3.09%+1.15% 155B
-2.01%-10.04%-28.95%+27.97% 138B
-2.35%-5.32%-56.67%-24.11% 60.85B
-1.95%-4.95%+19.64%+52.11% 58.56B
-1.96%-2.25%+2.85%-14.73% 52.46B
-2.83%-2.06%+12.65%+37.49% 48.04B
-3.51%-4.30%+11.79%+60.37% 43.29B
+1.26%-11.71%+9.08%+50.92% 43.1B
Average -1.02%-3.79%-1.87%+15.44% 85B
Weighted average by Cap. -2.42%-3.87%-1.95%+24.88%

Financials

2024 2025
Net sales 3.73M 2.48M 2.26M 2.08M 1.89M 3.55M 229M 25.29M 10.05M 125M 9.29M 9.09M 393M 2.58M 1.71M 1.56M 1.44M 1.31M 2.45M 159M 17.5M 6.96M 86.65M 6.43M 6.29M 272M
Net income -2.07M -1.38M -1.26M -1.16M -1.05M -1.97M -128M -14.08M -5.6M -69.72M -5.17M -5.06M -219M -3.3M -2.19M -2M -1.84M -1.68M -3.14M -203M -22.41M -8.91M -111M -8.23M -8.06M -348M
Net Debt -1.53M -1.02M -926K -853K -776K -1.46M -94.16M -10.39M -4.13M -51.43M -3.82M -3.73M -161M 1.3M 862K 785K 723K 658K 1.23M 79.8M 8.8M 3.5M 43.59M 3.23M 3.17M 137M
Projected Income Statement - Annual - Uscom Limited
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35